Mechanistic Insight into How PEGylation Reduces the Efficacy of pH-Sensitive Liposomes from Molecular Dynamics Simulations.


Journal

Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791

Informations de publication

Date de publication:
05 07 2021
Historique:
pubmed: 8 6 2021
medline: 11 1 2022
entrez: 7 6 2021
Statut: ppublish

Résumé

Liposome-based drug delivery systems composed of DOPE stabilized with cholesteryl hemisuccinate (CHMS) have been proposed as a drug delivery mechanism with pH-triggered release as the anionic form (CHSa) is protonated (CHS) at reduced pH; PEGylation is known to decrease this pH sensitivity. In this manuscript, we set out to use molecular dynamics (MD) simulations with a model with all-atom resolution to provide insight into why incorporation of poly(ethyleneglycol) (PEG) into DOPE-CHMS liposomes reduces their pH sensitivity; we also address two additional questions: (1) How CHSa stabilizes DOPE bilayers into a lamellar conformation at a physiological pH of 7.4? and (2) how the change from CHSa to CHS at acidic pH triggers the destabilization of DOPE bilayers? We found that (A) CHSa stabilizes the DOPE lipid membrane by increasing the hydrophilicity of the bilayer surface, (B) when CHSa changes to CHS by pH reduction, DOPE bilayers are destabilized due to a reduction in bilayer hydrophilicity and a reduction in the area per lipid, and (C) PEG stabilizes DOPE bilayers into the lamellar phase, thus reducing the pH sensitivity of the liposomes by increasing the area per lipid through penetration into the bilayer, which is our main focus.

Identifiants

pubmed: 34096310
doi: 10.1021/acs.molpharmaceut.1c00122
pmc: PMC8289284
doi:

Substances chimiques

Cholesterol Esters 0
Lipid Bilayers 0
Liposomes 0
Phosphatidylethanolamines 0
Polyethylene Glycols 3WJQ0SDW1A
cholesteryl succinate T3J4KS4201

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2612-2621

Références

Biochemistry. 1985 Mar 26;24(7):1654-61
pubmed: 4005220
Angew Chem Int Ed Engl. 2015 Oct 19;54(43):12743-7
pubmed: 26189870
Biochemistry. 1985 Jun 18;24(13):3099-106
pubmed: 4027232
Biochim Biophys Acta. 2009 Jan;1788(1):97-121
pubmed: 18823938
Chem Phys Lipids. 1986 Jun-Jul;40(2-4):127-44
pubmed: 3742670
Biochemistry. 1989 Mar 7;28(5):2322-30
pubmed: 2541783
Langmuir. 2020 Jun 23;36(24):6668-6680
pubmed: 32437159
J Phys Chem B. 2018 Apr 26;122(16):4546-4557
pubmed: 29608850
Biophys J. 2007 Feb 15;92(4):1114-24
pubmed: 17114222
Nanomedicine (Lond). 2019 Aug;14(15):1971-1989
pubmed: 31355712
J Chem Theory Comput. 2008 Mar;4(3):435-47
pubmed: 26620784
Chem Phys Lipids. 2014 Dec;184:82-104
pubmed: 25444976
Adv Colloid Interface Sci. 2019 Sep;271:101985
pubmed: 31351415
Biochim Biophys Acta. 2000 Jan 15;1463(1):107-14
pubmed: 10631299
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Langmuir. 2020 May 12;36(18):4908-4916
pubmed: 32295345
Front Pharmacol. 2015 Dec 01;6:286
pubmed: 26648870
Langmuir. 2010 Aug 3;26(15):12769-76
pubmed: 20666419
Biochemistry. 1988 Oct 4;27(20):7711-22
pubmed: 3207702
Mol Pharm. 2014 Nov 3;11(11):4059-68
pubmed: 25271780
J Control Release. 2019 Dec 10;315:1-22
pubmed: 31647978
Biochim Biophys Acta. 2016 Oct;1858(10):2334-2352
pubmed: 26915693
Phys Rev A Gen Phys. 1985 Mar;31(3):1695-1697
pubmed: 9895674
Mol Pharm. 2020 Feb 3;17(2):472-487
pubmed: 31789523
Biophys J. 1998 Feb;74(2 Pt 1):899-909
pubmed: 9533701
Colloids Surf B Biointerfaces. 2017 Mar 1;151:19-25
pubmed: 27940165
Biophys J. 1995 Dec;69(6):2521-30
pubmed: 8599659
J Am Chem Soc. 1988 Mar 1;110(6):1657-66
pubmed: 27557051
Biophys J. 2003 May;84(5):3111-22
pubmed: 12719241
Biophys J. 1998 Mar;74(3):1371-9
pubmed: 9512033
Mol Pharm. 2011 Dec 5;8(6):2224-32
pubmed: 21899300
Biochim Biophys Acta. 2009 May;1788(5):918-25
pubmed: 19248762
Proc Natl Acad Sci U S A. 1985 Sep;82(17):5742-5
pubmed: 3862092
Biochim Biophys Acta. 1992 Aug 14;1113(2):201-27
pubmed: 1510997
Biochim Biophys Acta. 2015 Feb;1848(2):422-32
pubmed: 25450348
J Mol Model. 2014 Feb;20(2):2121
pubmed: 24526383
Eur J Biochem. 1976 Feb 16;62(2):335-44
pubmed: 3416
Eur J Pharm Sci. 2017 May 30;103:128-135
pubmed: 28285174
Data Brief. 2015 Sep 26;5:333-6
pubmed: 26568975
J Mater Chem B. 2020 Sep 23;8(36):8242-8248
pubmed: 32794526
Int J Nanomedicine. 2007;2(4):595-607
pubmed: 18203427
Biol Pharm Bull. 2017;40(1):1-10
pubmed: 28049940
Nanomedicine. 2015 Aug;11(6):1575-84
pubmed: 25819885
Biophys J. 1995 May;68(5):1727-39
pubmed: 7612816
J Phys Chem B. 2012 Apr 12;116(14):4212-9
pubmed: 22420691
J Chem Theory Comput. 2020 Jan 14;16(1):738-748
pubmed: 31762275
Nat Prod Commun. 2012 Mar;7(3):353-8
pubmed: 22545410
Langmuir. 2011 Jun 21;27(12):7788-98
pubmed: 21604684
Biochemistry. 1984 Mar 27;23(7):1532-8
pubmed: 6722105
J Phys Chem B. 2014 May 1;118(17):4571-81
pubmed: 24745688
Chemistry. 2019 Jan 2;25(1):20-25
pubmed: 30133869
J Phys Chem B. 2010 Sep 16;114(36):11784-92
pubmed: 20726538
J Liposome Res. 2012 Jun;22(2):148-57
pubmed: 22149717
J Phys Chem B. 2010 Nov 25;114(46):14941-6
pubmed: 20977247
Biochemistry. 1986 Nov 18;25(23):7518-22
pubmed: 3801431
J Biol Chem. 1997 Jan 24;272(4):2382-8
pubmed: 8999949
Biochemistry. 1996 Feb 27;35(8):2610-7
pubmed: 8611564
Biophys J. 2005 Feb;88(2):1091-103
pubmed: 15556990
Faraday Discuss. 2013;161:249-72; discussion 273-303
pubmed: 23805746
Pharm Res. 1990 Aug;7(8):824-34
pubmed: 2172955
Eur J Pharm Sci. 2012 Jun 14;46(3):121-30
pubmed: 22381076
Ther Deliv. 2013 Sep;4(9):1099-123
pubmed: 24024511
Biomaterials. 2006 Apr;27(12):2599-608
pubmed: 16380161
Chem Phys Lipids. 2016 Feb;195:12-20
pubmed: 26187855
Mol Pharm. 2014 Mar 3;11(3):755-65
pubmed: 24467226
Adv Drug Deliv Rev. 2004 Apr 23;56(7):947-65
pubmed: 15066754

Auteurs

Mohammad Mahmoudzadeh (M)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, 00100 Helsinki, Finland.

Aniket Magarkar (A)

Medicinal Chemistry, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, D-88397 Biberach a.d. Riss, Germany.

Artturi Koivuniemi (A)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, 00100 Helsinki, Finland.

Tomasz Róg (T)

Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Viikinkaarie 5 E, FI-00014 Helsinki, Finland.

Alex Bunker (A)

Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Viikinkaarie 5 E, FI-00014 Helsinki, Finland.

Articles similaires

Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Aspergillus Hydrogen-Ion Concentration Coculture Techniques Secondary Metabolism Streptomyces rimosus
Fucosyltransferases Drug Repositioning Molecular Docking Simulation Molecular Dynamics Simulation Humans
Receptor, Cannabinoid, CB1 Ligands Molecular Dynamics Simulation Protein Binding Thermodynamics

Classifications MeSH